home / stock / cmmb / cmmb news

CMMB News and Press, Chemomab Therapeutics Ltd. From 02/19/25

Stock Information
Company Name: Chemomab Therapeutics Ltd.
Stock Symbol: CMMB
Market: NASDAQ
Website: chemomab.com
Menu
CMMB CMMB Quote CMMB Short CMMB News CMMB Articles CMMB Message Board
Get CMMB Alerts

News, Short Squeeze, Breakout and More Instantly...
CMMB - Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis

Single Positive Phase 3 Trial Designed to Support Full Regulatory Approval, For the First Time Providing Regulatory Clarity in PSC and Positioning Nebokitug to Potentially Become the First FDA-Approved Treatment for PSC No Liver Biopsies or Additional Confirmatory Studies Required—...
CMMB - Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

TEL AVIV, Israel, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that CEO Dr. Adi Mor and other members of its s...

Previous 10 Next 10